Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Centers for Disease Control and Prevention

May 13, Novel Influenza A (H1N1) - Congressional Update

We are providing this document to help inform Congress and congressional staff about the current status of the novel Influenza A (H1N1) events. Any questions should be directed to CDC/Washington at 202-245-0600.

Note: Green text indicates new information. Black text indicates background and other information also included in previous updates.

U.S. Update

As of May 13, 2009 11:00 AM ET, a total of 3352 confirmed human cases of novel Influenza A (H1N1) have been identified in the United States in 44 states and the District of Columbia. One hundred and thirty-three have been hospitalized. The median age is 15 and range from 1 to 87 years. There are approximately 604 additional probable cases currently being analyzed. There have been three deaths from novel Influenza A (H1N1), 2 in Texas and 1 in Washington. The total number of cases reported likely represents an underestimation of the actual total number of cases because in order for a case to be confirmed and reported infected individuals must visit a healthcare provider with flu-like symptoms and be tested for novel Influenza A (H1N1). CDC has 116 personnel deployed to CA, DE, IL, NYC, OH, TX, WA, and Washington, DC and at quarantine stations. Internationally, CDC has staff in Guatemala and Mexico.

A summary of the cases is provided below. There are also 604 probable cases. All questions related to specific cases should be directed to the state health department in the state in which the case occurred. A full list of state health departments and their contact information is available at http://www.astho.org/Programs/Infectious-Disease/H1N1/ under State H1N1 Information.

U.S. Human Cases of Novel Influenza A (H1N1) Infection
(As of May 13, 2009 11:00 AM ET)
State
# of laboratory confirmed cases
# deaths reported among laboratory confirmed cases
Alabama
9
-
Arizona
187
-
California
221
-
Colorado
44
-
Connecticut
33
-
Delaware
54
-
Florida
58
-
Georgia
8
-
Hawaii
6
-
Idaho
3
-
Illinois
592
-
Indiana
70
-
Iowa
55
-
Kansas
23
-
Kentucky**
10
-
Louisiana
33
-
Maine
6
-
Maryland
23
-
Massachusetts
107
-
Michigan
134
-
Minnesota
31
-
Missouri
18
-
Montana
1
-
Nebraska
21
-
Nevada
21
-
New Hampshire
17
-
New Jersey
8
-
New Mexico
44
-
New York
211
-
North Carolina
12
-
Ohio
11
-
Oklahoma
22
-
Oregon
74
-
Pennsylvania
22
-
Rhode Island
7
-
South Carolina
32
-
South Dakota
3
-
Tennessee
57
-
Texas
293
2
Utah
72
-
Virginia
17
-
Washington
176
1
Washington D.C.
9
-
Wisconsin
496
-
Total Count
3352 cases
3 deaths
Source: CDC (http://www.cdc.gov/h1n1flu/update.htm#statetable)
** Case is a resident of Kentucky but currently hospitalized in Georgia.

NOTE: Because of daily reporting deadlines, the state totals reported by CDC may not always be consistent with those reported by state health departments. If there is a discrepancy between these two counts, data from the state health departments should be used as the most accurate number.

International Update

The World Health Organization (WHO) is providing information on international Novel 2009 H1N1 flu outbreaks at: http://www.who.int/csr/disease/swineflu/en/index.html.

On April 29, 2009 WHO raised the level of influenza pandemic alert from phase 4 to phase 5. Information on WHO′s pandemic influenza phases is available at: http://www.who.int/csr/disease/avian_influenza/phase/en/index.html.

As of May 13, 2009 4:00 PM GMT, the Government of Mexico has reported 2059 laboratory confirmed cases, including 56deaths, of novel Influenza A (H1N1). The higher number of cases in Mexico reflects ongoing testing of previously collected specimens.

U.S. Human Cases of Novel Influenza A (H1N1) Infection
(As of May 13, 2009 4:00 PM GMT)
Country
# of laboratory confirmed cases reported by country with cases
# of deaths reported among laboratory confirmed cases
Argentina
1
-
Australia
1
-
Austria
1
-
Brazil
8
-
Canada
358
1
China, Hong Kong, Special Administrative Region
3
-
Columbia
6
-
Costa Rica
8
1
Denmark
1
-
El Salvador
4
-
Finland
1
-
France
13
-
Germany
12
-
Guatemala
3
-
Ireland
1
-
Israel
7
-
Italy
9
-
Japan
4
-
Mexico
2059
56
Netherlands
3
-
New Zealand
7
-
Norway
2
-
Panama
29
-
Poland
1
-
Portugal
1
-
Republic of Korea
3
-
Spain
98
-
Sweden
2
-
Switzerland
1
-
Thailand
2
-
United Kingdom
68
-
Total Count
2719 cases
58 deaths
Source: World Health Organization (http://www.who.int/csr/don/2009_05_08a/en/index.html)

Background information on novel Influenza A (H1N1):

Background Information About Novel Influenza A (H1N1)
Most recent updates to information from CDC on novel Influenza A (H1N1):
Information for individuals and parents on novel Influenza A (H1N1):
Travel notices related to Novel 2009 H1N1 flu:
Information on Novel 2009 H1N1 flu and pork
Resources and Information in Spanish:
What is CDCs recommendation regarding "swine flu parties"?
"Swine flu parties" are gatherings during which people have close contact with a person who has novel Influenza A (H1N1) in order to become infected with the virus. The intent of these parties is to become infected with what for many people has been a mild disease, in the hope of having natural immunity to the novel Influenza A (H1N1) virus that might circulate later and cause more severe disease.

"Swine flu parties" are not a safe or effective way to protect against novel Influenza A (H1N1) in the future. While the disease seen in the current novel Influenza A (H1N1) outbreak has been mild for many people, it has been severe and even fatal for others. There is no way to predict with certainty what the outcome will be for an individual or, equally important, for others to whom the intentionally infected person may spread the virus.

CDC recommends that people with novel Influenza A (H1N1) avoid contact with others as much as possible. They should stay home from work or school for 7 days after the onset of illness or until at least 24 hours after symptoms have resolved, whichever is longer.

New Materials to Assist Tribal Nations
CDC released a brochure, Preparing Tribal Nations to Receive Strategic National Stockpile Assets targeting American Indian and Alaska Native government leaders. The brochure is available at: http://www.cdc.gov/h1n1flu/pdf/preparing_tribal_national_stockpile.pdf.

Resources for Businesses and Employers
CDC has developed a Web site with resources for businesses and employers. The Web site includes guidance documents, podcasts and other resources developed by CDC to help prevent the further spread of this new virus available at: http://www.cdc.gov/h1n1flu/business/.

Guidance Documents

CDC has and continues to develop a number of guidance documents related to Novel 2009 H1N1 flu. The documents target a variety of clinical, professional, and individual audiences. The guidance documents are regularly updated as CDC continues to learn more about Novel 2009 H1N1 flu. All current guidance documents are available at: Novel 2009 H1N1 Flu Guidance. Guidance documents include:


Epidemiology and Surveillance

Clinician Guidance

Clinician Guidance for Specific Audiences

Infection Control

Laboratory Testing

Useful resources

  1. A public service announcement to provide information and guidance for recent fraudulent activity surrounding ads for flu remedies.
    Visit http://www.cdc.gov/h1n1flu/psa/consumerfraud.htm to listen to the announcement.
  2. A PowerPoint presentation to provide general information about H1N1 flu to employees, constituents and other partners is available at
    http://www.cdc.gov/h1n1flu/business/.

Guidance for Community Settings

Guidance for Patients

Guidance for Pregnant and Breastfeeding Women

Emergency Personnel Guidance

Other

Guidance for Schools, Colleges and University

Travel & Travel Industry Guidance

PSA for Children

How does CDC conduct influenza surveillance?

B00528 H1N1 FluThe Epidemiology and Prevention Branch in the Influenza Division at CDC collects, compiles and analyzes information on influenza activity year round in the United States and produces a weekly report from October through mid-May. The U.S. influenza surveillance system is a collaborative effort between CDC and its many partners in state and local health departments, public health and clinical laboratories, vital statistics offices, healthcare providers, clinics and emergency departments. Information in five categories is collected from nine different data sources.

  • Viral Surveillance About 80 U.S. World Health Organization (WHO) Collaborating Laboratories and 70 National Respiratory and Enteric Virus Surveillance System (NREVSS) laboratories, located throughout the United States, participate in virologic surveillance for influenza. All state public health laboratories participate as WHO collaborating laboratories along with some county public health laboratories and some large tertiary care or academic medical centers. Most NREVSS laboratories participating in influenza surveillance are hospital laboratories. In 2007, human infection with a novel influenza A virus became a nationally notifiable condition. The 2009 influenza A (H1N1) virus is a novel virus. Novel influenza A virus infections include all human infections with influenza A viruses that are different from currently circulating human influenza H1 and H3 viruses.
  • Outpatient Illness Surveillance Information on patient visits to health care providers for influenza-like illness is collected through the U.S. Outpatient Influenza-like Illness Surveillance Network (ILINet).
    • Mortality Surveillance Rapid tracking of influenza-associated deaths is done through two systems: 122 Cities Mortality Reporting System. Each week, the vital statistics offices of 122 cities report the total number of death certificates received and the number of those for which pneumonia or influenza was listed as the underlying or contributing cause of death by age group. The percentage of all deaths due to pneumonia and influenza (P&I) are compared with a seasonal baseline and epidemic threshold value calculated for each week.
    • Surveillance for Influenza-associated Pediatric Mortality. Influenza-associated deaths in children (persons less than 18 years) was added as a nationally notifiable condition in 2004. Laboratory-confirmed influenza-associated deaths in children are reported through the Nationally Notifiable Disease Surveillance System.
  • Hospitalization Surveillance Two systems monitor hospitalizations with laboratory confirmed influenza infections.
    • Emerging Infections Program (EIP). The EIP Influenza Project conducts surveillance for laboratory-confirmed influenza related hospitalizations in children (persons less than 18 years) and adults in 60 counties covering 12 metropolitan areas of 10 states (San Francisco CA, Denver CO, New Haven CT, Atlanta GA, Baltimore MD, Minneapolis/St. Paul MN, Albuquerque NM, Las Cruces, NM, Albany NY, Rochester NY, Portland OR, and Nashville TN).
    • New Vaccine Surveillance Network (NVSN). The New Vaccine Surveillance Network (NVSN) provides population-based estimates of laboratory-confirmed influenza hospitalization rates for children less than 5 years old residing in three counties: Hamilton County OH, Davidson County TN, and Monroe County NY.
  • Summary of the Geographic Spread of Influenza State health departments report the estimated level of spread of influenza activity in their states each week through the State and Territorial Epidemiologists Reports. States report influenza activity as no activity, sporadic, local, regional, or widespread.

For a more detailed explanation of these influenza surveillance systems visit: Flu Activity and Surveillance

HHS and CDC Roles

CDC is actively responding to and investigating the current outbreak of novel Influenza A (H1N1). CDC has fully activated its Emergency Operations Center. In addition to response and laboratory activities described above, 116 staff have been deployed and 34 pending deployment in the U.S., Mexico, and Guatemala to assist with the public health investigation. Staff are currently in California, Delaware, Illinois, New York City, Texas, Washington DC, and at U.S. quarantine stations. On April 21st CDC described the first two cases in a Morbidity and Mortality Weekly Report (MMWR), Swine Influenza A (H1N1) Infection in Two Children --- Southern California, March--April 2009 (http://www.cdc.gov/mmwr/preview/mmwrhtml/mm58d0421a1.htm). An MMWR describing additional cases was published on April 24th and is available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm58d0424a1.htm?s_cid=mm58d0424a1_e.

An example of CDCs response is the use of new communications modes to inform the public. Through its National Center for Health Marketing, CDC is using social media (www.cdc.gov/socialmedia) to provide H1N1 flu-related information when, where and how Americans want it. Ongoing social media activities include: posting information to CDC Facebook, MySpace, and DailyStrength social networking profiles; posting videos and podcasts to the CDC YouTube Channel; reaching out to blog writers to ensure credible information is being shared in blogs; sending email updates to users who have subscribed to receive information about the flu; developing widgets so that CDC flu information can be posted on other Web sites and blogs; and providing updated information to mobile phones. Congressional offices can point constituents to these interactive tools to get information, including:

For more information regarding CDCs novel Influenza A (H1N1) activities, go to: http://www.cdc.gov/h1n1flu/.

Pandemic Planning Investments at Work

In recent years, CDC has received congressional appropriations pandemic influenza activities.

CDC′s Pandemic Influenza Appropriations
Fiscal Year
Amount
2007
$70,000,000
2008
$154,632,000
2009
$156,046,000
Total Appropriations
$380,678,000

These recent investments have enhanced many areas critical to pandemic influenza preparedness and response, including health monitoring, epidemiology, laboratory capabilities, response, and recovery. The appropriated resources have allowed CDC to work with states and territories to test national infrastructure and develop operational plans, strengthen crisis communication plans and tools, expand the Strategic National Stockpile, improve surveillance systems, and work with international partners to prepare for a pandemic. All of these activities have increased both CDC′s and our partners′ capacity and capabilities for dealing with the current Novel 2009 H1N1 flu outbreak.

For more information about CDC′s pandemic influenza activities and appropriations, please contact CDC/Washington, at (202) 245-0600.

Where to Find Updates

CDC is committed to ensuring Congress, public health partners, the media, and the public are able to obtain up-to-date and accurate information regarding the human Novel 2009 H1N1 flu cases and CDC′s related activities. CDC is providing daily updates on our Web site. Information is available at: http://www.cdc.gov/h1n1flu/index.htm.

In addition, the World Health Organization (WHO) has additional information on the global situation at: http://www.who.int/csr/disease/swineflu/en/index.html. Many state health departments are adding or updating information on Novel 2009 H1N1 flu on their Web sites. A full list of state health departments and their contact information is available at http://www.astho.org/Programs/Infectious-Disease/H1N1/ under State H1N1 Information.

To the topTo The Top

 
Contact Washington Office:
  • For Hill Staffers and
    Washington-based Partners:

    Centers for Disease Control and Prevention
    Washington Office

    395 E Street, SW
    Suite 9100
    Washington, DC 20201
  • Telephone: (202) 245-0600
    Fax: (202) 245-0602 or (202) 245-0599
CDC Vital Signs™ – Learn about the latest public health data. Read CDC Vital Signs™…
  • Page last reviewed: February 2, 2010
  • Page last updated: February 2, 2010
  • Content source: Office of the Associate Director for Policy
  • Notice: Links to non-governmental sites do not necessarily represent the views of the CDC.
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348, New Hours of Operation 8am-8pm ET/Monday-Friday
Closed Holidays - cdcinfo@cdc.gov
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #